Episode Details

This is one of those stories that might not grab headlines right away… but probably should.In today’s episode, we’re breaking down a major milestone from Avicanna (TSX: AVCN), as their subsidiary SMGH completes its first commercial export of organic, CBG-dominant cannabis flower to Australia — one of the most tightly regulated medical markets in the world.On the surface, it’s an export story.But when you step back… it’s really about something bigger.For years, the industry has talked about whether cannabis can be grown more efficiently outside of North America — lower cost, better climate, scalable production. A lot of companies tried. Most didn’t make it.Now we’re starting to see what execution actually looks like.In this conversation, we get into:

• Why this export matters more than people think
• How Colombia is positioning itself in the global supply chain
• The role of organic cultivation and cost advantages
• And what this could mean for international medical markets moving forward

If you’re looking at where cannabis is heading over the next 3–5 years — especially from a global and supply chain perspective — this is one to pay attention to.#Avicanna #CannabisIndustry #MedicalCannabis #CannabisExports #CannabisInvesting #GlobalCannabis #CannabisStocks #CBG #CannabisNews #CannabisMarketWant to see more Cannabis Reform videos?🎬    • Medicare CBD Program Raises Questions In W...  🎬    • Does Cannabis Rescheduling Actually Unlock...  🎬    • Texas Hemp Ban Creates Winners And Losers ...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:

Listen Now